Why is there increased activity in animal health IPOs?

Just 18 months ago, there were no animal health IPOs. But ever since Pfizer ($PFE) spun off its animal health unit Zoetis ($ZTS) in February 2013, IPOs are flying. Husch Blackwell, a Kansas City, MO-based national legal firm with a Food & Agribusiness team, has laid out the top reasons behind the sudden rush--citing increased news coverage of the sector as one of them. And it's worth mentioning that Husch Blackwell even appointed a D.V.M. to its staff. Article

Suggested Articles

Payers are now holding up Spark's $850,000 gene therapy as an example of how innovative drug developers can help payers afford pricey new treatments.

Bayer’s pharma products have been growing lickety-split, and its 2016 numbers show just how—and how much. But with the big Monsanto merger top of mind at Bayer…

After two years of implementing an across-the-board efficiency plan, fine-tuning its product portfolio and getting manufacturing up to speed on Apoquel, animal…